Natera (NTRA) News Today $150.93 -3.96 (-2.56%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Natera (NasdaqGS:NTRA) Unveils DEFINE-HT Trial Insights in Heart Transplantation StudyApril 30 at 7:24 PM | finance.yahoo.comFirst Light Asset Management LLC Trims Stock Position in Natera, Inc. (NASDAQ:NTRA)First Light Asset Management LLC reduced its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 49.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 93,088 shares of the medical reApril 30 at 8:13 AM | marketbeat.com2 Healthcare Stocks on Our Watchlist and 1 to Be Wary OfApril 29 at 11:31 AM | msn.comNatera, Inc. (NASDAQ:NTRA) Stake Trimmed by Tri Locum Partners LPTri Locum Partners LP reduced its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 36.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 202,646 shares of the medical research company's stockApril 29 at 6:51 AM | marketbeat.comAquatic Capital Management LLC Acquires 24,724 Shares of Natera, Inc. (NASDAQ:NTRA)Aquatic Capital Management LLC increased its holdings in Natera, Inc. (NASDAQ:NTRA - Free Report) by 343.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,924 shares of the medical research company's stock afteApril 29 at 6:35 AM | marketbeat.comHsbc Holdings PLC Has $19.57 Million Holdings in Natera, Inc. (NASDAQ:NTRA)Hsbc Holdings PLC decreased its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 9.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 123,593 shares of the medical research company's stoApril 29 at 5:06 AM | marketbeat.comGilder Gagnon Howe & Co. LLC Decreases Stake in Natera, Inc. (NASDAQ:NTRA)Gilder Gagnon Howe & Co. LLC trimmed its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 7.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,286,728 shares of the medicalApril 28 at 6:28 AM | marketbeat.comLord Abbett & CO. LLC Sells 6,424,796 Shares of Natera, Inc. (NASDAQ:NTRA)Lord Abbett & CO. LLC lowered its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 81.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,440,435 shares of the medical research company's stock after selling 6,424,April 27 at 6:42 AM | marketbeat.comVoya Investment Management LLC Sells 3,875,910 Shares of Natera, Inc. (NASDAQ:NTRA)Voya Investment Management LLC lessened its holdings in Natera, Inc. (NASDAQ:NTRA - Free Report) by 89.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 448,280 shares of the medApril 27 at 6:18 AM | marketbeat.com2,548 Shares in Natera, Inc. (NASDAQ:NTRA) Purchased by Syon Capital LLCSyon Capital LLC bought a new stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,548 shares of the medical research comApril 27 at 5:59 AM | marketbeat.comScience & Technology Partners L.P. Invests $25.49 Million in Natera, Inc. (NASDAQ:NTRA)Science & Technology Partners L.P. purchased a new stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 161,022 shares of the medical research company's stock, valued at approximatApril 26, 2025 | marketbeat.comHood River Capital Management LLC Grows Position in Natera, Inc. (NASDAQ:NTRA)Hood River Capital Management LLC grew its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 5.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 41,648 shares of the medical research company's stock after purchasing an adApril 26, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Increases Stock Position in Natera, Inc. (NASDAQ:NTRA)Price T Rowe Associates Inc. MD increased its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 134.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,742,428 shares of the medical research company's stoApril 26, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Purchased by Tower Research Capital LLC TRCTower Research Capital LLC TRC raised its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 912.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,329 shares of the medical research company's stoApril 26, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) CFO Michael Burkes Brophy Sells 610 SharesNatera, Inc. (NASDAQ:NTRA - Get Free Report) CFO Michael Burkes Brophy sold 610 shares of the company's stock in a transaction that occurred on Monday, April 21st. The stock was sold at an average price of $145.55, for a total value of $88,785.50. Following the completion of the sale, the chief financial officer now owns 76,468 shares in the company, valued at $11,129,917.40. The trade was a 0.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.April 25, 2025 | marketbeat.comHarvest Investment Services LLC Purchases Shares of 3,848 Natera, Inc. (NASDAQ:NTRA)Harvest Investment Services LLC acquired a new position in Natera, Inc. (NASDAQ:NTRA - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 3,848 shares of the medical research company'sApril 25, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) CFO Sells $74,616.30 in StockApril 25, 2025 | insidertrades.comNatera, Inc. (NASDAQ:NTRA) Insider Sells $49,923.65 in StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) insider John Fesko sold 343 shares of the business's stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $145.55, for a total transaction of $49,923.65. Following the completion of the transaction, the insider now owns 156,946 shares in the company, valued at approximately $22,843,490.30. The trade was a 0.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.April 24, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) CEO Sells $242,195.20 in StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) CEO Steven Leonard Chapman sold 1,664 shares of the stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $145.55, for a total value of $242,195.20. Following the transaction, the chief executive officer now owns 198,365 shares of the company's stock, valued at $28,872,025.75. This represents a 0.83 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.April 24, 2025 | marketbeat.comNatera, Inc. (NTRA): One of the Best Aggressive Growth Stocks to Buy NowApril 24, 2025 | insidermonkey.comQuantessence Capital LLC Purchases Shares of 4,599 Natera, Inc. (NASDAQ:NTRA)Quantessence Capital LLC acquired a new stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 4,599 shares of the medical researchApril 24, 2025 | marketbeat.comEversept Partners LP Increases Stock Holdings in Natera, Inc. (NASDAQ:NTRA)Eversept Partners LP lifted its holdings in Natera, Inc. (NASDAQ:NTRA - Free Report) by 0.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 876,766 shares of the medical research company's stock after acquiring an additional 6,573 shaApril 24, 2025 | marketbeat.comNatera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD TestApril 24, 2025 | businesswire.comForum Financial Management LP Buys New Holdings in Natera, Inc. (NASDAQ:NTRA)Forum Financial Management LP purchased a new position in Natera, Inc. (NASDAQ:NTRA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,065 shares of the medical research company's stock, valued at approApril 24, 2025 | marketbeat.comMichael Burkes Brophy Sells 610 Shares of Natera, Inc. (NASDAQ:NTRA) StockApril 24, 2025 | insidertrades.comCanada Pension Plan Investment Board Has $10.51 Million Stake in Natera, Inc. (NASDAQ:NTRA)Canada Pension Plan Investment Board increased its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 14.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 66,400 shares of the medical research company's stock after purchasingApril 24, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Sold by First Trust Advisors LPFirst Trust Advisors LP decreased its holdings in Natera, Inc. (NASDAQ:NTRA - Free Report) by 12.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 572,637 shares of the medical research company's stock after sellApril 23, 2025 | marketbeat.comJohn Fesko Sells 343 Shares of Natera, Inc. (NASDAQ:NTRA) StockApril 23, 2025 | insidertrades.comNatera To Present Data from 8 Studies at 2025 AACR Annual MeetingApril 22, 2025 | businesswire.comTransatlantique Private Wealth LLC Invests $848,000 in Natera, Inc. (NASDAQ:NTRA)Transatlantique Private Wealth LLC bought a new stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 5,354 shares of the medical research company'sApril 22, 2025 | marketbeat.comThematics Asset Management Trims Holdings in Natera, Inc. (NASDAQ:NTRA)Thematics Asset Management reduced its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 23.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 49,333 shares of the medical research company's stock after selling 15,221 shares during the peApril 22, 2025 | marketbeat.comXTX Topco Ltd Purchases Shares of 3,460 Natera, Inc. (NASDAQ:NTRA)XTX Topco Ltd acquired a new position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 3,460 shares of the medical research company's stock, valued at approximately $548,000. SeverApril 22, 2025 | marketbeat.comBarclays PLC Sells 28,704 Shares of Natera, Inc. (NASDAQ:NTRA)Barclays PLC cut its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 20.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 111,411 shares of the medical research company's stock after selling 28,704 shares during the quarter.April 22, 2025 | marketbeat.comFormula Growth Ltd. Sells 3,800 Shares of Natera, Inc. (NASDAQ:NTRA)Formula Growth Ltd. cut its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 18.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,006 shares of the medical research company's stApril 21, 2025 | marketbeat.comBlue Water Life Science Advisors LP Reduces Holdings in Natera, Inc. (NASDAQ:NTRA)Blue Water Life Science Advisors LP reduced its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 12.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 254,794 shares of the medical research company's stock after selling 36,300 shares during the period. NaApril 20, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Holdings Lowered by Guggenheim Capital LLCGuggenheim Capital LLC cut its stake in Natera, Inc. (NASDAQ:NTRA - Free Report) by 21.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,917 shares of the medical research company's stock afterApril 20, 2025 | marketbeat.comOsterweis Capital Management Inc. Sells 8,595 Shares of Natera, Inc. (NASDAQ:NTRA)Osterweis Capital Management Inc. cut its stake in Natera, Inc. (NASDAQ:NTRA - Free Report) by 11.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 67,315 shares of the medical research company's stock aApril 19, 2025 | marketbeat.com1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Turn DownApril 18, 2025 | msn.comEAM Global Investors LLC Invests $4.64 Million in Natera, Inc. (NASDAQ:NTRA)EAM Global Investors LLC bought a new stake in Natera, Inc. (NASDAQ:NTRA - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 29,293 shares of the medical research company's stock, valuedApril 18, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Sold by Jump Financial LLCJump Financial LLC decreased its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 11.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,317 shares of the mediApril 18, 2025 | marketbeat.com1NTRA : Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth TodayApril 17, 2025 | benzinga.comNatera (NTRA) Gets a Buy from BernsteinApril 17, 2025 | markets.businessinsider.comNatera, Inc. (NASDAQ:NTRA) Shares Sold by Synovus Financial CorpSynovus Financial Corp reduced its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 18.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 19,303 shares of the medical resApril 17, 2025 | marketbeat.comPortolan Capital Management LLC Has $6.11 Million Position in Natera, Inc. (NASDAQ:NTRA)Portolan Capital Management LLC trimmed its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 53.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,594 shares of the medApril 16, 2025 | marketbeat.comSterling Capital Management LLC Purchases 12,580 Shares of Natera, Inc. (NASDAQ:NTRA)Sterling Capital Management LLC raised its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 608.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,647 shares of the medical research company's stApril 16, 2025 | marketbeat.comBank of Montreal Can Has $4.27 Million Stock Holdings in Natera, Inc. (NASDAQ:NTRA)Bank of Montreal Can lowered its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 63.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 26,985 shares of the medical research company's stock after selling 47,543 shares dApril 16, 2025 | marketbeat.comRussell Investments Group Ltd. Cuts Stock Holdings in Natera, Inc. (NASDAQ:NTRA)Russell Investments Group Ltd. lowered its holdings in Natera, Inc. (NASDAQ:NTRA - Free Report) by 21.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 31,175 shares of the medical research company's stock after selling 8,3April 16, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Bought by Wells Fargo & Company MNWells Fargo & Company MN raised its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 69.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 96,136 shares of the medical research company'sApril 16, 2025 | marketbeat.comImmuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs PeersApril 15, 2025 | finance.yahoo.comGranite Investment Partners LLC Has $8.36 Million Stock Holdings in Natera, Inc. (NASDAQ:NTRA)Granite Investment Partners LLC decreased its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 26.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 52,796 shares of the medical research coApril 15, 2025 | marketbeat.com Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address NTRA Media Mentions By Week NTRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTRA News Sentiment▼1.380.85▲Average Medical News Sentiment NTRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTRA Articles This Week▼2713▲NTRA Articles Average Week Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FMS News Today HIMS News Today GH News Today OPCH News Today RDNT News Today SHC News Today WGS News Today BTSG News Today PRVA News Today CON News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NTRA) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.